| A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) (NCT06585787) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2024-09-26 |
| First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study (NCT06616259) | Meng Qiu | 2024-09-26 |
| ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 (NCT06320431) | University of Calgary | 2024-09-26 |
| A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain Metastases (NCT06970639) | Allist Pharmaceuticals, Inc. | 2024-09-26 |
| A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise (NCT06672172) | Shandong Suncadia Medicine Co., Ltd. | 2024-09-25 |
| A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis (NCT06569056) | Jiangsu HengRui Medicine Co., Ltd. | 2024-09-25 |
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment (NCT06563245) | Children's Cancer Group, China | 2024-09-25 |
| A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) (NCT06660394) | Longboard Pharmaceuticals | 2024-09-25 |
| A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1) (NCT06525220) | Merus B.V. | 2024-09-25 |
| Bionic Pancreas in CFRD (NCT06449677) | Jaeb Center for Health Research | 2024-09-24 |
| A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy (NCT06481891) | Lexicon Pharmaceuticals | 2024-09-24 |
| A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis (NCT06592794) | ModernaTX, Inc. | 2024-09-24 |
| Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight (NCT06588296) | Eli Lilly and Company | 2024-09-24 |
| Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients (NCT06606093) | Daewoong Pharmaceutical Co. LTD. | 2024-09-23 |
| Clinical Research Study to Assess the Efficacy of Two Brushing Regimens (NCT06240481) | Colgate Palmolive | 2024-09-23 |
| Orthobiologic Treatment for Knee Osteoarthritis (NCT06893250) | University Hospital of North Norway | 2024-09-23 |
| Efficacy of Manual Toothbrushes in Removing Tooth Stains (NCT06486974) | Colgate Palmolive | 2024-09-23 |
| Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT） (NCT06559241) | Capital Medical University | 2024-09-23 |
| A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer (NCT06497556) | Hoffmann-La Roche | 2024-09-23 |
| Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio (NCT06570772) | Alvotech Swiss AG | 2024-09-23 |
| Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis (NCT06554847) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-09-23 |
| Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease (NCT07326904) | Indonesia University | 2024-09-23 |
| To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications (NCT06553027) | Cerevance | 2024-09-20 |
| 2 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma (NCT06492460) | Sun Yat-sen University | 2024-09-20 |
| To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection (NCT06561594) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2024-09-20 |
| Semaglutide in Treatment of Obesity (NCT06604624) | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | 2024-09-20 |
| Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold (NCT05070650) | Sandoz | 2024-09-20 |
| Virtual Reality Treatment for Emerging Adults With ADHD (NCT06454604) | Rutgers, The State University of New Jersey | 2024-09-20 |
| A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps (NCT06516302) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2024-09-19 |
| A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure (NCT06635135) | Janssen Research & Development, LLC | 2024-09-19 |
| Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis (NCT06554509) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2024-09-19 |
| A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation (NCT07406854) | Wuhan Neurophth Biotechnology Limited Company | 2024-09-19 |
| Hyaluronic Acid in Shoulder Tendinopathy (NCT06376981) | Centre Hospitalier Departemental Vendee | 2024-09-19 |
| A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis (NCT06558279) | argenx | 2024-09-18 |
| Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study) (NCT06726421) | Sun Yat-sen University | 2024-09-18 |
| Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm (NCT06863662) | Laboratorios Silanes S.A. de C.V. | 2024-09-18 |
| Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial (NCT06563388) | Roswell Park Cancer Institute | 2024-09-18 |
| Hyperbaric Oxygen Treatment for Veterans With Traumatic Brain Injury (NCT06581003) | University of South Florida | 2024-09-18 |
| A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (NCT06589986) | Hoffmann-La Roche | 2024-09-17 |
| Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension (NCT06258785) | Endeavor Health | 2024-09-17 |
| Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan (NCT06588413) | Augusta University | 2024-09-17 |
| IV vs Epidural Opioids + Epidural Local Anesthetic for Laparotomy Analgesia (NCT06559969) | University of Iowa | 2024-09-17 |
| Comparative Study to Evaluate the Efficacy of an Alcohol-free Mouthwash Regimen With CPC+Zn, Flossing and Brushing, and an Alcohol-based Mouthwash Regimen With Essential Oils in Reducing Plaque and Gingivitis. (NCT06598072) | Colgate Palmolive | 2024-09-17 |
| Extended Oral Tranexamic Acid After Total Knee Arthroplasty (NCT06618820) | Campbell Clinic | 2024-09-17 |
| REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women (NCT06399692) | Weill Medical College of Cornell University | 2024-09-16 |
| JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer (NCT06581380) | JenKem Technology Co., Ltd. | 2024-09-16 |
| Comparative Study of CPC+Zn Mouthwash, Dental Floss, and Essential Oils Mouthwash on Plaque and Gingivitis Reduction (NCT06607263) | Colgate Palmolive | 2024-09-16 |
| A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age (NCT06602024) | ModernaTX, Inc. | 2024-09-16 |
| Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) (NCT06615557) | VistaGen Therapeutics, Inc. | 2024-09-16 |
| Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient (NCT06587542) | Universitas Padjadjaran | 2024-09-15 |
| Effects of Sevoflurane vs Desflurane on Early Recovery and Cognitive Function in Elderly Patients Undergoing Scheduled Non-Cardiac Surgery (NCT07289945) | Hopital Charles Nicolle | 2024-09-15 |
| A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty (NCT06510764) | Children's Hospital of Fudan University | 2024-09-15 |
| Clinical Study of Probiotic Treatment for Androgenetic Alopecia (NCT06484881) | Applied Biology, Inc. | 2024-09-15 |
| The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylori Infection (NCT06591494) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-09-15 |
| Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC (NCT06496048) | Luye Pharma Group Ltd. | 2024-09-14 |
| A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults (NCT06783114) | Chongqing Claruvis Pharmaceutical Co., Ltd. | 2024-09-14 |
| Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD (NCT06431256) | Ironshore Pharmaceuticals and Development, Inc | 2024-09-13 |
| A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population (NCT06585540) | Benaroya Research Institute | 2024-09-13 |
| A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT06547333) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2024-09-13 |
| Coenzyme Q10 for Gulf War Illness: A Replication Study (NCT06515184) | University of California, San Diego | 2024-09-13 |
| A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN) (NCT06584916) | Eli Lilly and Company | 2024-09-13 |
| The Prevent Coronary Artery Disease Trial (NCT06494501) | Icahn School of Medicine at Mount Sinai | 2024-09-12 |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients With Mild to Moderately Active Ulcerative Colitis (NCT06488625) | University Hospital Schleswig-Holstein | 2024-09-12 |
| Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab) (NCT06430866) | Amgen | 2024-09-12 |
| Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population (NCT06436781) | RDC Clinical Pty Ltd | 2024-09-12 |
| Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) (NCT06437977) | Shanghai Chest Hospital | 2024-09-12 |
| Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders) (NCT06496581) | UNICANCER | 2024-09-12 |
| ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension (NCT06418711) | Mannkind Corporation | 2024-09-11 |
| A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis (NCT06431373) | Priovant Therapeutics, Inc. | 2024-09-11 |
| Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas (NCT06422806) | National Cancer Institute (NCI) | 2024-09-11 |
| A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease (NCT06572384) | GlaxoSmithKline | 2024-09-11 |
| The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder (NCT06247839) | Sharmin Ghaznavi | 2024-09-10 |
| Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection (NCT06734260) | Eighth Affiliated Hospital, Sun Yat-sen University | 2024-09-10 |
| A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell Lymphoma (NCT06548347) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2024-09-10 |
| Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection. (NCT06593665) | Indiana University | 2024-09-10 |
| Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine (NCT06417775) | AbbVie | 2024-09-10 |
| PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. (NCT06274047) | M.D. Anderson Cancer Center | 2024-09-10 |
| A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer (NCT06692166) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2024-09-10 |
| A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer (NCT06311721) | Amgen | 2024-09-09 |
| A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) (NCT06246916) | Regeneron Pharmaceuticals | 2024-09-09 |
| Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies (NCT06652633) | Lakefront Biotherapeutics NV | 2024-09-09 |
| Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation (NCT06863636) | Laboratorios Silanes S.A. de C.V. | 2024-09-09 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM) (NCT06920771) | HAL Allergy | 2024-09-09 |
| Topical Tacrolimus for Breast Cancer-related Lymphedema (NCT06306274) | Odense University Hospital | 2024-09-09 |
| Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty (NCT06202989) | KAZM Pharmaceuticals Inc. | 2024-09-09 |
| Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma (NCT07168473) | Daewon Pharmaceutical Co., Ltd. | 2024-09-09 |
| Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients (NCT06531642) | The University of Texas Health Science Center, Houston | 2024-09-07 |
| Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) (NCT06577519) | Jiangsu vcare pharmaceutical technology co., LTD | 2024-09-06 |
| Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy (NCT06567821) | Cedars-Sinai Medical Center | 2024-09-04 |
| The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (NCT06058585) | The George Institute | 2024-09-04 |
| Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis (NCT07137819) | Aresus Pharma GmbH | 2024-09-04 |
| A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis (NCT06550076) | Takeda | 2024-09-04 |
| Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome (NCT06011889) | National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | 2024-09-04 |
| A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH (NCT06528314) | Akero Therapeutics, Inc | 2024-09-04 |
| Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial (NCT05744219) | Jon Unosson | 2024-09-04 |
| Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition (NCT06512584) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2024-09-03 |
| A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection (NCT06635798) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2024-09-03 |
| Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery (NCT05334485) | Stefan Holubar MD MS FACS, FASCRS | 2024-09-03 |
| HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents (NCT06554184) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-09-03 |
| A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty (NCT06545097) | Tris Pharma, Inc. | 2024-09-03 |